Like many of our customers, you are probably wondering why this isn’t already widespread. Unfortunately, Liposomal technology is incredibly difficult to work with especially with a compound as hydrophobic as CBD, which does not like being contained! We have been working on these formulations for over a year and they are now ready to be tried by our consumers. Keep reading to see why liposomes are so special and the future of CBD.
What Is Liposomal Delivery System?
Our body is compromised of trillions of cells that all act in unison to perform everything we do as humans. While each of these cells are unique, they all share similar cellular parts including a cellular membrane, which behaves like the cell’s “container”. This cellular membrane is also responsible for moving compounds in and out of the cell as well as reacting with compounds floating by. This can be incredibly efficient for compounds like electrolytes, but can also be incredibly inefficient for things like CBD and other compounds.
First discovered in 1964 by British hematologist Dr. Alec Bangham, liposomes were quickly realized to have potential as a drug delivery system due to their ability to increase bioavailabilty and also alter the absorption rate of pharmaceutical drugs.
Researcher Ranu Kumari Dutta,, describes liposomes as, “Liposomes are a novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are dispersed in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.”
As technology has advanced, it is now economically feasible for liposomes to be used outside of expensive pharmaceutical drugs. Over the last five years, research teams, including Medterra’s team, have studied liposomes for the use in dietary supplements.
Liposomes are made out of the same material as cell membranes making them biodegradable and bioavailable. This means that they enhance the absorption of vitamins, substances, and even CBD oil.
What Is Liposomal CBD?
Liposomal CBD is CBD that has been encapsulated in liposome specifically designed to hold CBD. Unlike traditional CBD, the outside of a liposome is in fact hydrophilic (loves to be in water). Given that humans are comprised of 60% water, liposomal CBD is very easily processed by the body and does not need to be processed by the liver. At Medterra, our liposomes provide up to 17x bioavailability, when compared to ingested CBD oil. As a product, lipsomal CBD can be consumed through both oral and topical formulations.
When used orally in an oil or capsule, liposomal CBD has the potential for a more accurate dose. However, with topicals, CBD can penetrate the skin deeper with a more pronounced effect.
In 2003, researchers administered transdermal CBD using ethosomes, another carrier comparable to liposomes that enter the skin’s layers.
The study determined that when CBD is delivered through small protective capsules like ethosomes or liposomes, there is significant CBD in the skin and muscle, and a considerable reduction in inflammation.
To start benefiting from liposomes CBD oil, try Medterra’s new Good Morning and Good Night Liposmal Capsules.
